Certain support cells in glioblastoma are linked to shorter survival
Original title: Pericyte-derived cancer-associated fibroblasts correlate with poor survival and are enriched after chemoradiotherapy in glioblastoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This studied tumor data in the lab and did not test a treatment.
The short version
Scientists found a type of support cell in glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary that is linked to worse outcomes.
What was studied. Researchers looked at gene activity in glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary tumors. They used 54 sets of single-cell data and 88 tumor samples.
What they found. A type of support cell, called CAFs, likely comes from cells that wrap around blood vessels. Tumors with more of these cells were linked to shorter survival and to the tumor growing again sooner. These cells were more common after chemo and radiation, and in more aggressive tumors.
What this means, and what it doesn't
What it could mean: This helps scientists understand how glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary may change after treatment. It gives them a new type of cell to study.
What it doesn't mean: This is early lab research using tumor data. It did not test any treatment. It does not change care today. It is not a cure, and it cannot predict how any one person will do.
Source: PubMed, September 10, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.